Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Weekly 1.25% fluoride gel vs placebo for white spot lesion development after orthodontic treatment
2010-020538-24Phase 4Completed
- Sponsor
- Colgate-Palmolive
- Start
- Nov 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of olaflur in enamel subsurface lesion (2 arms), sponsored by Colgate-Palmolive. Primary endpoint: Primary: Change in DWL%t from baseline (T0) to 12 weeks (T4). Started Nov 2010; status: completed.
02
Drugs
olaflur
03
Conditions
enamel subsurface lesion
Beyond the preview
Go deeper on 2010-020538-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-020538-24.